Abelchia: A Clinical Review of Retrograde Cricopharyngeus Dysfunction and Inability to Belch for Gastroenterologists
Abelchia, also termed the inability to belch syndrome, is an increasingly recognized upper esophageal sphincter (UES) disorder characterized by retrograde cricopharyngeal dysfunction (RCPD). This disorder is highly relevant to gastroenterologists since presentation consists of common upper gastrointestinal symptoms including chest pain, gurgling noises in the chest, abdominal pressure, and bloating, often misattributed to alternate foregut disorders. Abelchia is thought to result from absent or incomplete UES relaxation in response to retrograde esophageal air distension, causing esophageal air trapping, despite preserved anterograde swallowing-related UES relaxation. The diagnosis is suspected based on clinical presentation and absence of alternate esophageal structural/motor disorders and supported by high-resolution impedance manometry with carbonated beverage challenge. Injection of botulinum toxin into the UES during rigid esophagoscopy is the mainstay of treatment, though data supporting this are largely derived from case series. Symptom benefit typically outlasts the general duration of efficacy of botulinum toxin, suggesting retraining of retrograde UES relaxation and the ability to belch. Consequently, behavioral therapy has been also reported to be of benefit. Randomized trials, standardized diagnostic criteria, and long-term outcome studies are lacking. This review summarizes the evolving literature on abelchia with emphasis on clinical presentation, diagnostic evaluation, differential diagnosis, treatment, and the role of gastroenterologists in identifying this underrecognized disorder.
Authors
- Stephanie E. Teng (ORCID: https://orcid.org/0000-0001-9775-3831)
- Pavan S. Mallur (ORCID: https://orcid.org/0000-0001-8086-0534)
- Judy W. Nee (ORCID: https://orcid.org/0000-0002-9437-4163)
- Adrianna Wierzbicka (ORCID: https://orcid.org/0009-0003-4043-791X)
- Trisha Satya Pasricha (ORCID: https://orcid.org/0000-0002-8859-0361)
- Anthony J Lembo (ORCID: https://orcid.org/0000-0002-4479-1188)
- Ofer Z. Fass (ORCID: https://orcid.org/0000-0003-4947-6192)
- Johanna Iturrino (ORCID: https://orcid.org/0000-0003-2280-2488)
- Sarah Ballou (ORCID: https://orcid.org/0000-0002-6746-1958)
- Evan Wilder
- Chandra Prakash Gyawali (ORCID: https://orcid.org/0000-0002-3388-0660)
- Chethan Ramprasad (ORCID: https://orcid.org/0000-0003-1812-248X)
- Vikram Rangan (ORCID: https://orcid.org/0000-0001-9804-958X)
- Louise Halbert (ORCID: https://orcid.org/0009-0009-3448-7068)
- Prashant Singh (ORCID: https://orcid.org/0000-0002-3796-2372)
- Baha Moshiree (ORCID: https://orcid.org/0000-0003-4986-7134)
- Ashley McCarthy (ORCID: https://orcid.org/0009-0000-4161-7670)
- Abelchia Working Group
- Jacqueline Wolf (ORCID: https://orcid.org/0000-0002-7748-394X)
Institutions
- Northwestern University (US)
- Atrium Health Wake Forest Baptist (US)
- Beth Israel Deaconess Medical Center (US)
- Cleveland Clinic (US)
- Harvard University (US)
- Washington University in St. Louis (US)
- University of Michigan (US)
- Cleveland Clinic Florida (US)
- Michigan Medicine (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.14309/ajg.0000000000004264
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00